Patient Adherence Program Design

Not Found

Sorry, but no results were found. Please use our navigation or search to find what you are looking for.

How will the addition of step therapy on Medicare Part B drugs impact biosimilars?

Increase use of biosimilars: 54.55%

No Change: 36.36%

Decrease biosimilar use: 9.09%

Will deeply discounted WAC prices (list price) for biosimilars and specialty generics influence uptake?

Yes: 28.6%

Some impact: 57.1%

No: 14.3%

What is your opinion on pharmacists being allowed to refuse to dispense a prescription for ethical reasons?

Agree: 12.5%

Agree, if they can find another reasonable option for the patient: 56.25%

Disagree: 25%

Indifferent: 6.25%